Pancreatic Cancer Research

ResearcherNational Cancer CenterActive in the last 2 years

Hyeong Min Park

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7579-0241; OpenAlex author ID A5042307461. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 4 papers

Papers 9

  1. Increased diagnosis of hepato-biliary-pancreatic cancer after cholecystectomy: a population-based study. Co-author DOI 10.1038/s41598-024-84781-7↗
  2. Mutant KRAS and GATA6 Stratify Survival in Patients Treated with Chemotherapy for Pancreatic Adenocarcinoma: A Prospective Cohort Study. Co-author DOI 10.3390/cancers17050896↗
  3. Diagnostic Biomarker Candidates Proposed Using Targeted Lipid Metabolomics Analysis of the Plasma of Patients with PDAC. Co-author DOI 10.3390/cancers17182988↗
  4. Epidemiology and survival analysis according to the histologic subtype of pancreatic cancer: a population-based cohort study. Co-author DOI 10.4174/astr.2025.108.1.20↗
  5. Conditional Relative Survival of Exocrine Pancreatic Cancer: A Population-Based Study. Co-author DOI 10.1245/s10434-023-14594-x↗
  6. Exocrine pancreatic cancer as a second primary malignancy: A population-based study. Co-author DOI 10.14701/ahbps.23-053↗
  7. Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea. Co-author DOI 10.3346/jkms.2022.37.e216↗
  8. First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017. Co-author DOI 10.4143/crt.2021.421↗
  9. Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancrea… Co-author DOI 10.1186/s12885-019-6255-3↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sung‐Sik Han · 8 shared papers, 2019–2025 · strength 1.80
  2. Sang‐Jae Park · 8 shared papers, 2019–2025 · strength 1.80
  3. Mee Joo Kang · 6 shared papers, 2022–2025 · strength 1.43
  4. Kyu‐Won Jung · 3 shared papers, 2022–2025 · strength 0.76
  5. Young‐Joo Won · 3 shared papers, 2022–2023 · strength 0.54
  6. Sun‐Whe Kim · 3 shared papers, 2022–2023 · strength 0.54
  7. Jung Won Chun · 2 shared papers, 2025 · strength 0.45
  8. Woo Jin Lee · 2 shared papers, 2025 · strength 0.45
  9. Sang Myung Woo · 2 shared papers, 2025 · strength 0.45
  10. Young Ae Kim · 1 shared paper, 2025 · strength 0.30
  11. Soo‐Youl Kim · 1 shared paper, 2025 · strength 0.23
  12. Mi Rim Lee · 1 shared paper, 2025 · strength 0.22
  13. Tae Hyun Kim · 1 shared paper, 2025 · strength 0.22
  14. Sun‐Young Kong · 1 shared paper, 2025 · strength 0.22
  15. Yun‐Hee Kim · 1 shared paper, 2025 · strength 0.22
  16. Seong Hoon Kim · 1 shared paper, 2019 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.